Discover how to navigate inflation with long-term investments in resilient companies like Coca-Cola, AbbVie, and TC Energy.

Even after a flurry of corporate updates during the first two days of the J.P. Morgan Healthcare Conference, many more ...

While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...

New immunology products Skyrizi (risankizumab ... AbbVie’s head of commercial Jeff Stewart said on the results call that the two products have “substantial room for continued growth ...

If you live in the United States, you’ve likely seen drug commercials like this one: “If you’re living with moderate to severe plaque psoriasis or active psoriatic arthritis, symptoms can sometimes ...

Trump’s pick to lead the Health Department is targeting a multibillion-dollar ad market that’s one of the biggest spenders on ...

According to analysts, over the next few years, two blockbuster drugs, Skyrizi and Rinvoq ... company that specializes in residential and commercial water heaters for its consumers.

Marla has worked in the healthcare industry since 2000, starting as a bench chemist with Pfizer in manufacturing. In 2006, ...

The draw of both Otezla and tapinarof is that they are avoid the regular injections needed for biologic psoriasis therapies like Novartis' Cosentyx (secukinumab) and AbbVie's Skyrizi (risankizumab ...

However, AbbVie’s successful development and launch of next-gen immunology drugs Skyrizi and Rinvoq should enable revenues and earnings to grow strongly from its trough earnings-per-share (EPS ...

However, AbbVie’s successful development and launch of next-gen immunology drugs Skyrizi and Rinvoq should enable revenues and earnings to grow strongly from its trough earnings-per-share (EPS ...

The US Food and Drug Administration (FDA) has approved Omvoh (mirikizumab-mrkz), from US pharma major Eli Lilly, for the ...